Publications

  1. Bogenberger JM, Kornblau SM, Pierceall WE, Lena R, Chow D, Shi CX, Mantei J, Ahmann G, Gonzales IM, Choudhary A, Valdez R, Camoriano J, Fauble V, Tiedemann RE, Qiu YH, Coombes KR, Cardone M, Braggio E, Yin H, Azorsa DO, Mesa RA, Stewart AK, Tibes R. BCL-2 family proteins as 5-Azacytidine-sensitizing targets and determinants of response in myeloid malignancies. Leukemia. 2014 Jan 23.
    View PubMed
  2. Ghobrial IM, Witzig TE, Gertz M, Laplant B, Hayman S, Camoriano J, Lacy M, Bergsagel PL, Chuma S, Deangelo D, Treon SP. Long-term results of the phase II trial of the oral mTOR inhibitor everolimus (RAD001) in relapsed or refractory Waldenstrom Macroglobulinemia. Am J Hematol. 2014; 89(3):237-42.
  3. Hakim FA, Singh S, Pandit A, Alegria JR, Camoriano J, Stanton ML, Mookadam F. Interferon-α and pericardial injury: a case report and literature review. Heart Asia. 2014; 6:48-53.
  4. Dispenzieri A, Armitage JO, Loe MJ, Geyer SM, Allred J, Camoriano JK, Menke DM, Weisenburger DD, Ristow K, Dogan A, Habermann TM. The clinical spectrum of Castleman's disease. Am J Hematol. 2012 Nov; 87(11):997-1002. Epub 2012 Jul 13.
    View PubMed
  5. Gowin K, Thapaliya P, Samuelson J, Harrison C, Radia D, Andreasson B, Mascarenhas J, Rambaldi A, Barbui T, Rea CJ, Camoriano J, Gentry A, Kiladjian JJ, O'Connell C, Mesa R. Experience with pegylated interferon alpha-2a in advanced myeloproliferative neoplasms in an international cohort of 118 patients. Haematologica. 2012 Oct; 97(10):1570-3. Epub 2012 Mar 14
    View PubMed
  6. Alberts SR, Reid JM, Morlan BW, Farr GH Jr, Camoriano JK, Johnson DB, Enger JR, Seay TE, Kim GP. Gemcitabine and docetaxel for hepatocellular carcinoma: a phase II North Central Cancer Treatment Group clinical trial. Am J Clin Oncol. 2012 Oct; 35(5):418-23.
    View PubMed
  7. Cherington C, Slack JL, Leis J, Adams RH, Reeder CB, Mikhael JR, Camoriano J, Noel P, Fauble V, Betcher J, Higgins MS, Gillette-Kent G, Tremblay LD, Peterson ME, Olsen JJ, Tibes R, Mesa RA. Allogeneic stem cell transplantation for myeloproliferative neoplasm in blast phase. Leuk Res. 2012 Sep; 36(9):1147-51. Epub 2012 May 11.
    View PubMed
  8. Hendrickson AE, Oberg AL, Glaser G, Camoriano JK, Peethambaram PP, Colon-Otero G, Erlichman C, Ivy SP, Kaufmann SH, Karnitz LM, Haluska P. A phase II study of gemcitabine in combination with tanespimycin in advanced epithelial ovarian and primary peritoneal carcinoma. Gynecol Oncol. 2012 Feb; 124(2):210-5. Epub 2011 Nov 01.
    View PubMed
  9. Thapaliya P, Tefferi A, Pardanani A, Steensma DP, Camoriano J, Wu W, Geyer S, Mesa RA. International working group for myelofibrosis research and treatment response assessment and long-term follow-up of 50 myelofibrosis patients treated with thalidomide-prednisone based regimens. Am J Hematol. 2011 Jan; 86(1):96-8.
    View PubMed
  10. Ghobrial IM, Gertz M, Laplant B, Camoriano J, Hayman S, Lacy M, Chuma S, Harris B, Leduc R, Rourke M, Ansell SM, Deangelo D, Dispenzieri A, Bergsagel L, Reeder C, Anderson KC, Richardson PG, Treon SP, Witzig TE. Phase II trial of the oral mammalian target of rapamycin inhibitor everolimus in relapsed or refractory Waldenstrom macroglobulinemia. J Clin Oncol. 2010 Mar 10; 28(8):1408-14. Epub 2010 Feb 08.
    View PubMed
  11. Schuster SR, Burnette BL, De Petris G, Harmon CE, Camoriano JK, Ross HJ. Paraneoplastic polymyositis associated with mesothelioma: A brief report. Community Oncol. 2010; 7(4):178-80.
    View PubMed
  12. Mesa RA, Schwager S, Radia D, Cheville A, Hussein K, Niblack J, Pardanani AD, Steensma DP, Litzow MR, Rivera CE, Camoriano J, Verstovsek S, Sloan J, Harrison C, Kantarjian H, Tefferi A. The Myelofibrosis Symptom Assessment Form (MFSAF): an evidence-based brief inventory to measure quality of life and symptomatic response to treatment in myelofibrosis. Leuk Res. 2009 Sep; 33(9):1199-203. Epub 2009 Feb 27.
    View PubMed
  13. Steensma DP, Heptinstall KV, Johnson VM, Novotny PJ, Sloan JA, Camoriano JK, Niblack J, Bennett JM, Mesa RA. Common troublesome symptoms and their impact on quality of life in patients with myelodysplastic syndromes (MDS): results of a large internet-based survey. Leuk Res. 2008 May; 32(5):691-8. Epub 2007 Dec 4
    View PubMed
  14. Alberts SR, Suman VJ, Pitot HC, Camoriano JK, Rubin J. Use of KW-2189, a DNA Minor Groove-Binding Agent, in Patients with Hepatocellular Carcinoma: A North Central Cancer Treatment Group (NCCTG) Phase II Clinical Trial. Int J Gastrointest Cancer. 2008 Jan 03. [Epub ahead of print]
    View PubMed
  15. Mesa RA, Camoriano JK, Geyer SM, Wu W, Kaufmann SH, Rivera CE, Erlichman C, Wright J, Pardanani A, Lasho T, Finke C, Li CY, Tefferi A. A phase II trial of tipifarnib in myelofibrosis: primary, post-polycythemia vera and post-essential thrombocythemia. Leukemia. 2007 Sep; 21(9):1964-70. Epub 2007 Jun 21.
    View PubMed
  16. Haddock MG, Swaminathan R, Foster NR, Hauge MD, Martenson JA, Camoriano JK, Stella PJ, Tenglin RC, Schaefer PL, Moore DF Jr, Alberts SR. Gemcitabine, cisplatin, and radiotherapy for patients with locally advanced pancreatic adenocarcinoma: results of the North Central Cancer Treatment Group Phase II Study N9942. J Clin Oncol. 2007 Jun 20; 25(18):2567-72.
    View PubMed
  17. Ruiz-Arguelles GJ, Garces-Eisele J, Reyes-Nunez V, Ruiz-Delgado GJ, Rosillo C, Camoriano JK. Clearance of the Janus kinase 2 (JAK2) V617F mutation after allogeneic stem cell transplantation in a patient with myelofibrosis with myeloid metaplasia. Am J Hematol. 2007 May; 82(5):400-2.
    View PubMed
  18. Mesa RA, Niblack J, Wadleigh M, Verstovsek S, Camoriano J, Barnes S, Tan AD, Atherton PJ, Sloan JA, Tefferi A. The burden of fatigue and quality of life in myeloproliferative disorders (MPDs) - an international internet-based survey of 1179 MPD patients. Cancer. 2007 Jan 1; 109(1):68-76.
    View PubMed
  19. Alberts SR, Suman VJ, Pitot HC, Camoriano JK, Rubin J. Use of KW-2189, a DNA minor groove-binding agent, in patients with hepatocellular carcinoma: a north central cancer treatment group (NCCTG) phase II clinical trial. J Gastrointest Cancer. 2007; 38(1):10-4.
    View PubMed
  20. Tefferi A, Barosi G, Mesa RA, Cervantes F, Deeg HJ, Reilly JT, Verstovsek S, Dupriez B, Silver RT, Odenike O, Cortes J, Wadleigh M, Solberg LA Jr, Camoriano JK, Gisslinger H, Noel P, Thiele J, Vardiman JW, Hoffman R, Cross NC, Gilliland DG, Kantarjian H, International Working Group (IWG) consensus criteria for treatment response in myelofibrosis with myeloid metaplasia, for the IWG for Myelofibrosis Research and Treatment (IWG-MRT). Blood. 2006 Sep 1; 108(5):1497-503. Epub 2006 May 04.
    View PubMed
  21. Pardanani A, Ketterling RP, Li CY, Patnaik MM, Wolanskyj AP, Elliott MA, Camoriano JK, Butterfield JH, Dewald GW, Tefferi A. FIP1L1-PDGFRA in eosinophilic disorders: prevalence in routine clinical practice, long-term experience with imatinib therapy, and a critical review of the literature. Leuk Res. 2006 Aug; 30(8):965-70. Epub 2006 Jan 06.
    View PubMed
  22. Delaunoit T, Burch PA, Reid JM, Camoriano JK, Kobayash T, Braich TA, Kaur JS, Rubin J, Erlichman C. A phase I clinical and pharmacokinetic study of CS-682 administered orally in advanced malignant solid tumors. Invest New Drugs. 2006 Jul; 24(4):327-33.
    View PubMed
  23. Ingle JN, Suman VJ, Rowland KM, Mirchandani D, Bernath AM, Camoriano JK, Fishkin PA, Nikcevich DA, Perez EA, North Central Cancer Treatment Group Trial N0032. Fulvestrant in women with advanced breast cancer after progression on prior aromatase inhibitor therapy: North Central Cancer Treatment Group Trial N0032. J Clin Oncol. 2006 Mar 1; 24(7):1052-6.
    View PubMed
  24. Bobis KG, Camoriano JK, Wright MJ. The Office of Advanced Technology: providing focus on the piloting and implementation of new technology. J Healthc Inf Manag. 2004; 18(4):27-32.
    View PubMed
  25. Bobis KG, Camoriano J. Managing technology in a physician-led organization. J Healthc Inf Manag. 2003 Spring; 17(2):24-31.
    View PubMed
  26. Tefferi A, Mesa RA, Gray LA, Steensma DP, Camoriano JK, Elliott MA, Pardanani A, Ansell SM, Call TG, Colon-Otero G, Schroeder G, Hanson CA, Dewald GW, Kaufmann SH. Phase 2 trial of imatinib mesylate in myelofibrosis with myeloid metaplasia. Blood. 2002 May 15; 99(10):3854-6.
    View PubMed
  27. Burch PA, Richardson RL, Cha SS, Sargent DJ, Pitot HC 4th, Kaur JS, Camoriano JK. Phase II study of paclitaxel and cisplatin for advanced urothelial cancer. J Urol. 2000 Nov; 164(5):1538-42.
    View PubMed
  28. Loprinzi CL, Kugler JW, Sloan JA, Mailliard JA, Krook JE, Wilwerding MB, Rowland KM Jr, Camoriano JK, Novotny PJ, Christensen BJ. Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia. J Clin Oncol. 1999 Oct; 17(10):3299-306.
    View PubMed
  29. Harold KL, Schlinkert RT, Mann DK, Reeder CB, Noel P, Fitch TR, Braich TA, Camoriano JK. Long-term results of laparoscopic splenectomy for immune thrombocytopenic purpura. Mayo Clin Proc. 1999 Jan; 74(1):37-9.
    View PubMed
  30. Witzig TE, Camoriano JK, Schroeder G, Kurtin PJ, Habermann TM. A phase I trial of high dose ProMACE-CytaBOM with granulocyte colony stimulating factor for patients with non-Hodgkin's lymphoma. Leuk Lymphoma. 1998 Jan; 28(3-4):307-14.
    View PubMed
  31. Rajkumar SV, Frytak S, Rubin J, Camoriano JK, Fitch TR. Combination chemotherapy with cisplatin, carboplatin, and etoposide in advanced malignancy: a phase I trial. Am J Clin Oncol. 1997 Oct; 20(5):500-4.
    View PubMed
  32. Colon-Otero G, Marschke R, Camoriano JK, Sorensen JM, Sloan JA, Richardson RL. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas. Cancer J Sci Am. 1997 Sep-Oct; 3(5):297-302.
    View PubMed
  33. Ingle JN, Johnson PA, Suman VJ, Gerstner JB, Mailliard JA, Camoriano JK, Gesme DH Jr, Loprinzi CL, Hatfield AK, Hartmann LC. A randomized phase II trial of two dosage levels of letrozole as third-line hormonal therapy for women with metastatic breast carcinoma. Cancer. 1997 Jul 15; 80(2):218-24.
    View PubMed
  34. Loprinzi CL, Ghosh C, Camoriano J, Sloan J, Steen PD, Michalak JC, Schaefer PL, Novotny PJ, Gerstner JB, White DF, Hatfield AK, Quella SK. Phase III controlled evaluation of sucralfate to alleviate stomatitis in patients receiving fluorouracil-based chemotherapy. J Clin Oncol. 1997 Mar; 15(3):1235-8.
    View PubMed
  35. Halyard MY, Camoriano JK, Culligan JA, Weiland LH, Allen MS, Pluth JR, Pairolero PC. Malignant fibrous histiocytoma of the lung. Report of four cases and review of the literature. Cancer. 1996 Dec 15; 78(12):2492-7.
    View PubMed
  36. Menke DM, Tiemann M, Camoriano JK, Chang SF, Madan A, Chow M, Habermann TM, Parwaresch R. Diagnosis of Castleman's disease by identification of an immunophenotypically aberrant population of mantle zone B lymphocytes in paraffin-embedded lymph node biopsies. Am J Clin Pathol. 1996 Mar; 105(3):268-76.
    View PubMed
  37. Gharagozloo F, Dausmann MJ, Whitaker MD, Camoriano JK, Parish JM, McReynolds SD, Hall KA, Pluth JR. Thoracoscopic excision of a peripheral corticotropin-secreting pulmonary carcinoid tumor. Mayo Clin Proc. 1994 Jun; 69(6):594-6.
    View PubMed
  38. Menke DM, Camoriano JK, Banks PM. Angiofollicular lymph node hyperplasia: a comparison of unicentric, multicentric, hyaline vascular, and plasma cell types of disease by morphometric and clinical analysis. Mod Pathol. 1992 Sep; 5(5):525-30.
    View PubMed
  39. Camoriano JK, Loprinzi CL, Ingle JN, Therneau TM, Krook JE, Veeder MH. Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer. J Clin Oncol. 1990 Aug; 8(8):1327-34.
    View PubMed
  40. Sodhi N, Camilleri M, Camoriano JK, Low PA, Fealey RD, Perry MC. Autonomic function and motility in intestinal pseudoobstruction caused by paraneoplastic syndrome. Dig Dis Sci. 1989 Dec; 34(12):1937-42.
    View PubMed
  41. van Haelst-Pisani CM, Gleich GJ, Leiferman KM, Sorenson JM, Camoriano JK, Schray AG, O'Connell MJ, Kovah JS. Eosinophil Major Basic Protein as a Marker of IL-2 Induced Eosinophil Degranulation in Man. Proceedings of ASCO. 1989 Mar; 8:700.
  42. Arnold RW, Adams BA, Camoriano JK, Dyer JA. Acquired divergent strabismus: presumed metastatic gastric carcinoma to the medial rectus muscle. Journal of Pediatric Ophthalmology & Strabismus. 1989 Jan-Feb; 26(1):50-1.
    View PubMed
  43. Camoriano JK, Greipp PR, Bayer GK, Bowie EJ. Resolution of acquired factor X deficiency and amyloidosis with melphalan and prednisone therapy. N Engl J Med. 1987 Apr 30; 316(18):1133-5.
    View PubMed